Sex differences in the ACTH response to 24H metyrapone in depression

Brain Res. 2006 Dec 18;1126(1):148-55. doi: 10.1016/j.brainres.2006.05.053. Epub 2006 Jul 7.

Abstract

Increased hypothalamic-pituitary-adrenal (HPA) axis activation has been observed in major depression. Increased corticotropin-releasing hormone (CRH) is hypothesized to drive corticotropin (ACTH) secretion leading to increased ACTH and cortisol secretion throughout 24H. Contradicting data exist as to whether the increased drive is present throughout the day or is restricted to the late afternoon and evening. To determine if increased HPA axis activation occurs during a specific circadian phase or is found throughout the 24H, we studied 26 healthy drug-free depressed patients and 26 healthy age- and sex-matched control subjects under metyrapone inhibition of cortisol synthesis for 24H beginning at 4 PM. Blood was drawn every 10 min for 24H and assayed for ACTH and cortisol. Gender differences in response to metyrapone were seen in both patients and controls. Depressed women demonstrated increased ACTH concentrations between 4 PM and 10 PM compared to control women. Maximal ACTH response over time was identical between depressed and control women. Depressed men demonstrated significantly decreased ACTH secretion between 4 and 10 PM as well as decreased maximal ACTH response compared to control men or depressed women. These data support an increased evening CRH drive in depressed women, but overall decreased CRH drive in depressed men.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adrenal Cortex / drug effects
  • Adrenal Cortex / metabolism
  • Adrenal Cortex / physiopathology
  • Adrenocorticotropic Hormone / blood
  • Adrenocorticotropic Hormone / metabolism*
  • Adult
  • Antimetabolites / pharmacology
  • Circadian Rhythm / drug effects*
  • Circadian Rhythm / physiology
  • Depressive Disorder / blood*
  • Depressive Disorder / physiopathology
  • Female
  • Humans
  • Hydrocortisone / antagonists & inhibitors
  • Hydrocortisone / biosynthesis
  • Hypothalamo-Hypophyseal System / drug effects*
  • Hypothalamo-Hypophyseal System / metabolism
  • Hypothalamo-Hypophyseal System / physiopathology
  • Male
  • Metyrapone / pharmacology*
  • Middle Aged
  • Pituitary-Adrenal System / drug effects
  • Pituitary-Adrenal System / metabolism
  • Pituitary-Adrenal System / physiopathology
  • Sex Characteristics*

Substances

  • Antimetabolites
  • Adrenocorticotropic Hormone
  • Hydrocortisone
  • Metyrapone